Let’s be honest. Everyone who drinks alcohol, binges. The only question is how often.
To begin drinking is to open the door to a binge somewhere down the line, because alcohol does not simply depress the nervous system—it engages the same reward circuitry that opioids do. Alcohol triggers the release of endogenous opioids, particularly β-endorphin, from the hypothalamic arcuate nucleus, and these peptides then bind to mu-opioid receptors in the ventral tegmental area and nucleus accumbens, producing the euphoria and reinforcement that make drinking pleasurable (Gianoulakis, 2009; Herz, 1997). This is precisely why naltrexone—an opioid antagonist—reduces craving and blunts the reward of drinking: it blocks the binding of the endogenous opioid peptides that alcohol has released (Oasa et al., 2024). The pull toward a binge isn’t a character flaw. It’s a pharmacological consequence of the drug itself.
And the difference between staying fit until ninety and cirrhosis at fifty isn’t whether you binge. It’s how often.
The threshold is lower than you think, and the category is broader than you want it to be.
The Definition You Have Been Avoiding
The National Institute on Alcohol Abuse and Alcoholism defines binge drinking as a pattern that brings blood alcohol concentration to 0.08 per cent or higher—typically five or more drinks for men, four or more for women, in about two hours (NIAAA, 2024). Four drinks in two hours. That isn’t a bender. That’s a dinner party.
Now the number that should end the denial: more than half of all the alcohol adults drink is consumed during binge drinking occasions (CDC, 2024). Not in the single glass of red with dinner. Not in the beer you nurse for an hour. In the sessions where the pace accelerates and the count climbs past four. The “moderate drinker” who has four glasses of wine at a wedding isn’t a moderate drinker that night. He’s a binge drinker that night. And the accumulating evidence suggests that this pattern—not the weekly average—is what determines what happens to the liver, the heart, the sleep, and the face.
The J-Curve Is Dead
For decades, the alcohol industry and a generation of epidemiology textbooks sold the same story: moderate drinking is cardioprotective, red wine is good for the heart, the French live longer because of the resveratrol. The J-curve—the graph showing lower mortality at moderate intake—was the single most useful piece of marketing ever handed to an industry that sells a Group 1 carcinogen.
It doesn’t survive contact with better methods. A prospective study of 500,000 men and women in China used genetic variants that affect alcohol metabolism—essentially a randomized experiment built into the population—and found that alcohol increased the risk of stroke and had no protective effect on any cardiovascular outcome (Millwood et al., 2019). The J-curve, the authors concluded, was an artifact of comparing drinkers to abstainers who had quit because they were already sick. Remove that confounding and the curve flattens. The protection disappears. The harm remains.
The World Health Organization has stated it plainly: no level of alcohol consumption is safe for our health (WHO, 2023). Alcohol is a Group 1 carcinogen, in the same category as tobacco and asbestos, with the strongest causal links to cancers of the mouth, throat, oesophagus, liver, colorectum, and breast. The acetaldehyde produced when the body metabolizes ethanol is the carcinogen, and it damages DNA directly.
None of this means a single glass will kill you. It means the dose-response has no safe threshold, and the only levers you control are the total lifetime dose and the pattern in which you take it.
What the Binge Actually Does
The liver is the organ most people think of, and they’re right to. But the mechanism is the point. Moderate daily drinking produces a steady low-grade insult that the liver can repair between sessions. A binge produces an acetaldehyde spike, a burst of oxidative stress, and a transient inflammatory cascade—and the damage is concentrated in the hours after the session, not spread evenly across the month. Repeated binges accumulate the same total dose with less recovery time per unit. That’s why the interval matters so much.
But the liver isn’t the only casualty, and for a man who cares about the archetype we’ve been discussing in this series, the rest of the list is the one that should get his attention.
Sleep. Alcohol is a sedative that destroys sleep architecture. It reduces REM sleep and increases fragmentation in the second half of the night, which is why a heavy night produces a wired, unrested morning (Ebrahim et al., 2013). Sleep is when growth hormone peaks, when muscle repair happens, when skin regenerates, and when the brain consolidates memory. A binge trades one night’s sleep for a day of grogginess and a week of hormonal debt.
Body composition. Alcohol is 7 calories per gram, empty of nutrients, and metabolized before fat and carbohydrates. A heavy night adds a thousand calories and suppresses fat oxidation for the duration. It also suppresses muscle protein synthesis and lowers testosterone—the hormone that drives the physique the model archetype is built on. The “beer belly” isn’t a joke. It’s a metabolic fact.
Skin. Alcohol is a diuretic. It dehydrates the skin, dilates the blood vessels near the surface, and damages collagen over time. The face of the heavy drinker isn’t a myth. It’s the result of years of vasodilation, dehydration, and oxidative stress—the same mechanisms that age the liver, applied to the tissue everyone can see.
Testosterone and fertility. Chronic heavy drinking lowers testosterone, reduces sperm quality, and disrupts the hormonal feedback loop that regulates both (Emanuele & Emanuele, 1998). For a man in his twenties or thirties building an image, a physique, or a career, this isn’t a minor side effect. It’s direct competition with the archetype he’s trying to occupy.
The Protocol, Stated Honestly
Here is what a harm-reduction framework looks like for someone who isn’t dependent and doesn’t intend to stop. It isn’t a clinical protocol. It’s a set of heuristics, chosen to minimize frequency, minimize peak BAC, and maximize recovery time between sessions.
Typical session: 2–3 glasses of wine, maximum. This is a social amount. It doesn’t produce a binge BAC. It doesn’t disrupt sleep architecture materially. It doesn’t suppress testosterone meaningfully. It’s the dose at which the pleasure and the social function are present and the damage is minimal.
Absolute ceiling in a single sitting: 4–6. For a man, five drinks in two hours crosses the NIAAA threshold. For a woman, four does. At the ceiling, you’re in binge territory, and you should treat the session as such—not as a normal night out, but as an event with a cost.
Binge frequency: every two months. The interval that matters is the one that lets the last binge clear the system before the next one lands, and that interval is defined by the biomarkers.
Phosphatidylethanol, or PEth, is a direct alcohol biomarker that accumulates in red blood cell membranes and stays detectable for two to four weeks after a heavy drinking episode (Ulwelling & Smith, 2018). Gamma-glutamyl transferase, the classic liver enzyme, normalizes over two to six weeks (Conigrave et al., 2003). Carbohydrate-deficient transferrin follows a similar timeline. Six weeks is the point at which the direct marker has cleared and the indirect markers have had time to normalize. Not the point at which the liver is repaired—the point at which the clinical trace of the last binge is gone.
Six weeks is an awkward number to live by. Nobody tracks a calendar in six-week blocks. Two months is easier to calculate, easier to remember, and slightly more conservative than the clearance timelines require. So the rule is simple: every two months, not every month. The man who binges on the first weekend of January, March, May, July, September, and November is bingeing six times a year, with eight weeks of recovery between each event. The man who binges every month is bingeing twelve times, with four weeks between events—and four weeks isn’t enough for the liver enzymes to normalize, which means each binge lands on tissue that hasn’t finished recovering from the last one.
Six binges a year. Twelve. Fifty-two. That’s the whole argument, and it’s an argument about arithmetic, not willpower. The man who thinks he’s moderate because he “only drinks on weekends” is measuring the wrong thing. He isn’t spacing the events. He’s compounding them.
But there is a category the two-month rule doesn’t cover. If your liver has ever felt tender after a binge—a dull ache under the right ribcage, a soreness when you press on the area—you are not in the two-month category. You are in a different one.
Liver repair takes longer, up to a year in moderate cases not involving severe fibrosis.
Tenderness means inflammation. It means the liver is swollen enough to stretch its own capsule, which is packed with nerve endings (ScienceInsights, 2026). That is alcoholic hepatitis, even if it’s mild. Mild alcoholic hepatitis resolves with sobriety, but the timeline is not weeks. Significant improvement takes about three months. Full recovery can take six to twelve months, and in some cases longer (Phuket Island Rehab, 2026). One source describes the range bluntly: the rebuilding process can require a year or even longer (ABC Zdrowie, 2026).
So the rule is: if your liver has felt tender after a binge, be sober for at least the following year. Non-negotiable. You are not spacing binges at that point—you are letting an inflamed organ finish a repair job that takes months. The two-month interval is for the man whose liver has never complained. The one-year interval is for the man whose liver has.
That’s the honest version. The biomarkers tell you when the last binge’s trace is gone. The tenderness tells you when the liver itself is talking. Listen to the second one.
The daily-drinking trap. A man who drinks two glasses of wine every night isn’t bingeing. He’s also not safe. His weekly total is fourteen drinks, which exceeds the moderate-drinking guidance for men in most national guidelines, and his lifetime dose will exceed that of the man who binges six times a year. The daily habit is more dangerous than the occasional binge, not less, because it never gives the system a recovery window. Frequency cuts both ways. Daily is a frequency too.
Let’s be honest: a daily drinker does it for the moderate high. Exercise gives you the same endorphins with zero cost to your liver. If you find yourself drinking daily, switch your evening beer or glass of wine to coffee, tea, yerba maté or chaga, and take a morning walk instead. You’ll look better in the mirror within a month or two, I promise.
The Medicine Is Not a Slogan
Here is where the honest version of this essay parts company with the motivational version.
For a man who isn’t dependent, the choice between being sexy and being a binge drinker is a real choice with real consequences, and the framing is useful. He can look at the face, the physique, the sleep, and the career, and decide that the trade isn’t worth it. That’s a decision, and decisions work.
For a man who is dependent—who can’t stop at four, who drinks to feel normal, who has tried to cut back and failed—the choice framing isn’t medicine. It’s an insult, and it delays treatment. The evidence-based treatments for alcohol use disorder are naltrexone (which reduces craving and blunts the reward), acamprosate (which supports abstinence), and behavioral therapies including motivational enhancement and cognitive-behavioral approaches (Jonas et al., 2014). Naltrexone in particular has the advantage of being usable on a targeted basis—taken before a drinking occasion, it reduces the reinforcement that drives the habit. These are real medications with real evidence. A slogan is not.
If you can hold the protocol, hold it. If you can’t, that’s not a character flaw. It’s a diagnosis, and it has a treatment.
Pick One
You can be the man with the skin, the sleep, the physique, the hormonal profile, and the long runway of health that allows you to be a male model at 70+. Or you can be the man who drinks a six-pack of beer every Friday and pays for it in the mirror.
The choice isn’t between drinking and not drinking. It’s about how often, and how much, and whether the trade is one you’d make on purpose rather than one you drift into. The occasional binge, spaced widely, is survivable. The daily habit isn’t. The weekly binge isn’t. The man who tells himself he’s moderate because he only drinks on weekends is measuring the wrong thing.
Pick one.
References
CDC. (2024). Binge drinking: Data and statistics. Centers for Disease Control and Prevention.
Conigrave, K. M., Davies, P., Haber, P., & Whitfield, J. B. (2003). Traditional markers of excessive alcohol use. Addiction, 98(s2), 31–43.
Ebrahim, I. O., Shapiro, C. M., Williams, A. J., & Fenwick, P. B. (2013). Alcohol and sleep I: Effects on normal sleep. Alcoholism: Clinical and Experimental Research, 37(4), 539–549.
Emanuele, M. A., & Emanuele, N. V. (1998). Alcohol’s effects on male reproduction. Alcohol Health and Research World, 22(3), 195–201.
Gianoulakis, C. (2009). Endogenous opioids and addiction to alcohol and other drugs of abuse. Current Topics in Medicinal Chemistry, 9(11), 999–1015.
Herz, A. (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology, 129(2), 99–111.
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., & Garbutt, J. C. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis. JAMA, 311(18), 1889–1900.
Millwood, I. Y., Walters, R. G., Mei, X. W., Guo, Y., Yang, L., Bian, Z., … & Chen, Z. (2019). Conventional and genetic evidence on alcohol and vascular disease aetiology: A prospective study of 500,000 men and women in China. The Lancet, 393(10183), 1831–1842.
National Institute on Alcohol Abuse and Alcoholism. (2024). Understanding alcohol drinking patterns. NIAAA.
Oasa, S., Sezgin, E., Ma, Y., Horne, D. A., Radmilovic, M. D., Jovanovic-Talisman, T., Martin-Fardon, R., Vukojević, V., & Terenius, L. (2024). Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane. Translational Psychiatry, 14, 477.
Ulwelling, W., & Smith, K. (2018). The PEth blood test in the security environment: What it is; why it is important; and interpretative guidelines. Journal of Forensic Sciences, 63(6), 1634–1640.
World Health Organization. (2023). No level of alcohol consumption is safe for our health. The Lancet Public Health, 8(1), e6.